Shomron Ben-Horin

}} Shomron Ben-Horin (born 1968) (Hebrew: שומרון בן-חורין) is an Israeli physician, a co-founder & Chief Medical Officer of Evinature, and professor of medicine at the Tel-Aviv University.

Shomron Ben-Horin was born and raised in Tel Aviv, Israel.

He received his MD from the Hadassah School of Medicine of the Hebrew University of Jerusalem before completing his gastroenterology training at Sheba Medical Center in Tel Aviv. Provided by Wikipedia
Showing 1 - 20 results of 40 for search 'Shomron Ben-Horin', query time: 0.07s Refine Results
  1. 1
    Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis

    Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis by Shomron Ben-Horin, Uri Kopylov, Nir Salomon

    Published 2022-09-01
    Get full text
    Article
  2. 2
    Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort

    Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort by Adi Lahat, Herma H Fidder, Shomron Ben-Horin

    Published 2020-05-01
    Get full text
    Article
  3. 3
    Change in bowel habits during menstruation: are IBD patients different?

    Change in bowel habits during menstruation: are IBD patients different? by Adi Lahat, Alona Falach-Malik, Ola Haj, Zina shatz, Shomron Ben- Horin

    Published 2020-06-01
    Get full text
    Article
  4. 4
    Acute Chest Pain as an Infusion Reaction to Vedolizumab

    Acute Chest Pain as an Infusion Reaction to Vedolizumab by Asaf Levartovsky, Miri Yavzori, Ella Fudim, Uri Kopylov, Shomron Ben-Horin, Bella Ungar

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?

    Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet? by Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Eyal Klang, Shelly Soffer, Uri Kopylov

    Published 2020-08-01
    Get full text
    Article
  6. 6
    Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics

    Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics by Shelly Soffer, Eyal Klang, Noam Tau, Roni Zemet, Shomron Ben-Horin, Yiftach Barash, Uri Kopylov

    Published 2020-07-01
    Get full text
    Article
  7. 7
    The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?

    The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease? by Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Benjamin Avidan, Shomron Ben-Horin, Rami Eliakim, Uri Kopylov

    Published 2018-01-01
    Get full text
    Article
  8. 8
    Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease

    Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease by Offir Ukashi, Doron Yablecovitch, Adi Lahat, Limor Selinger, Sandra Neuman, Rami Eliakim, Shomron Ben-Horin, Uri Kopylov

    Published 2023-07-01
    Get full text
    Article
  9. 9
    Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection

    Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection by Offir Ukashi, Yiftach Barash, Eyal Klang, Tal Zilberman, Bella Ungar, Uri Kopylov, Shomron Ben-Horin, Ido Veisman

    Published 2022-03-01
    Get full text
    Article
  10. 10
    Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study

    Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study by Ido Veisman, Oranit Barzilay, Liora Bruckmayer, Ola Haj-Natour, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Bella Ungar

    Published 2021-09-01
    Get full text
    Article
  11. 11
    The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy

    The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy by Dan Carter, Lior H. Katz, Eytan Bardan, Eti Salomon, Shulamit Goldstein, Shomron Ben Horin, Uri Kopylov, Rami Eliakim

    Published 2018-03-01
    Get full text
    Article
  12. 12
    Predictors of mortality in inflammatory bowel disease patients treated for pneumonia

    Predictors of mortality in inflammatory bowel disease patients treated for pneumonia by Offir Ukashi, Yifatch Barash, Michael J. Segel, Bella Ungar, Shelly Soffer, Shomron Ben-Horin, Eyal Klang, Uri Kopylov

    Published 2020-07-01
    Get full text
    Article
  13. 13
    Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department

    Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department by Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Shelly Soffer, Marianne M. Amitai, Eyal Klang, Uri Kopylov

    Published 2021-10-01
    Get full text
    Article
  14. 14
    Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals

    Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals by Offir Ukashi, Barak Pflantzer, Yiftach Barash, Eyal Klang, Shlomo Segev, Doron Yablecovitch, Uri Kopylov, Shomron Ben-Horin, Ido Laish

    Published 2022-06-01
    Get full text
    Article
  15. 15
    Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study

    Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study by Hussein Mahajna, Yiftach Barash, Bella Ungar, Shelly Soffer, Ahmad Albshesh, Asaf Levartovsky, Shomron Ben-Horin, Eyal Klang, Uri Kopylov

    Published 2020-11-01
    Get full text
    Article
  16. 16
    Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

    Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis by Yuen Sau Tham, Diana E. Yung, Shmuel Fay, Takayuki Yamamoto, Shomron Ben-Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov

    Published 2018-06-01
    Get full text
    Article
  17. 17
    Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

    Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease? by Asaf Levartovsky, Ido Cohen, Chaya Mushka Abitbol, Miri Yavzori, Ella Fudim, Orit Picard, Uri Kopylov, Shomron Ben-Horin, Bella Ungar

    Published 2023-05-01
    Get full text
    Article
  18. 18
    Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to target

    Factors associated with the achievement of mucosal healing in Crohn’s disease: the benefit of endoscopic monitoring in treating to target by Ren Mao, Yun Qiu, Bai-Li Chen, Sheng-Hong Zhang, Rui Feng, Yao He, Zhi- Rong Zeng, Shomron Ben-Horin, Min-Hu Chen

    Published 2017-06-01
    Get full text
    Article
  19. 19
    Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center

    Biologic Treatment Modification Efficacy in Concurrent Inflammatory Bowel Disease and Ankylosing Spondylitis: A Retrospective Cohort Study at a Single Tertiary Center by Einat Savin, Niv Ben-Shabat, Asaf Levartovsky, Adi Lahat, Mahmud Omar, Omer Gendelman, Merav Lidar, Abdulla Watad, Shomron Ben-Horin, Uri Kopylov, Kassem Sharif

    Published 2023-11-01
    Get full text
    Article
  20. 20
    Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis

    Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis by Asaf Levartovsky, Tal Ovdat, Yiftach Barash, Zohar Ben-Shatach, Yael Skinezes, Stuart Jesin, Robert Klempfner, Ehud Grossman, Uri Kopylov, Shomron Ben-Horin, Bella Ungar

    Published 2022-08-01
    Get full text
    Article

Search Tools: